Project Grants
Backgrounder
[ News Release: The Government of Canada invests over $21M in innovative health research ]
Project Grants are designed to support researchers at any career stage build and conduct health research and knowledge translation projects covering a range of areas, from discovery science and clinical research to strengthening the health care system and examining the social determinants of health.
In the most recent Project Grants competition, CIHR provided $14.4M to support 18 researchers at Laval University.
| Researcher | Project | Funding Amount |
|---|---|---|
| Dr. Patrick Archambault | Supporting the creation of a LEARNing INteGrated health system to mobilize context-adapted knowledge with a Wiki platform to Improve the transitions of frail Seniors from from hospitals and emergency Departments to the cOMmunity: the LEARNING WISDOM Phase II scale-up project | $1.47M |
| Dr. Jean-François Bilodeau | Isoprostanes and phospholipases A2: Roles in the pathophysiology of preeclampsia | $662,000 |
| Dr. Elyse Bissonnette | CD200 dysregulation in asthma: potential for therapy? | $643,000 |
| Dr. Mohamed Chahine | Investigating the role of gating pore current in cardiac arrhythmias associated with dilated cardiomyopathy | $1.03M |
| Dr. Paul De Koninck | Optical nanoscopy of cytoskeletal and synaptic remodeling in neurons | $784,000 |
| Dr. Sabine Elowe | Towards a comprehensive model of Spindle Assembly Checkpoint silencing | $536,000 |
| Dr. Amélie Fradet-Turcotte | Defining the molecular basis of chemoradiation sensitivity in HPV+ head and neck cancers. | $696,000 |
| Dr. Chantal Guillemette | Function of the glucuronosyltransferase pathway in chronic lymphocytic leukemia | $639,000 |
| Dr. Samer Hussein | The role of long non-coding RNAs in defining pluripotent stem cell states | $799,000 |
| Dr. Mathieu Laplante | Molecular mechanisms of adipose tissue development | $696,000 |
| Dr. Jean-Yves Masson | Roles of the tumor suppressor PALB2 at the crossroads of DNA double-strand break repair and synthetic lethal strategies | $968,000 |
| Dr. Donald Poirier | Développement d'un traitement sélectif de l'endométriose : Étude du potentiel du premier inhibiteur irréversible de la 17beta-HSD1 chez le primate | $363,000 |
| Dr. Armen Saghatelyan | Deciphering the role of autophagy in neuronal migration and maturation | $991,000 |
| Dr. François Gros-Louis | Pathogenic Pathways and in-vitro modelization of Intracranial Aneurysms in populations of Inuit and French Canadian descent | $952,425 |
| Dr. Sébastien Hébert | microRNA-132: from underlying mechanism of neurodegeneration to therapeutic application in Huntington's disease | $573,750 |
| Dr. Michel G Maziade | Intercepting the "childhood risk syndrome" of schizophrenia and mood disorders along the developmental trajectory: A preclinical staging of children and adolescents at genetic risk | $852,975 |
| Dr. Thomas Moss | Mechanism of Ribosomal RNA Gene Silencing and Its Roles in Pluripotency and Cancer | $1,074,060 |
| Dr. Martin Parent | La modulation des ganglions de la base par les afférences neurochimiques du tronc cérébral: implication dans la physiopathologie des troubles du mouvement | $738,225 |
Page details
- Date modified: